Table 3.
Baseline population demographics of included patients.
| No. of studies | HP | CP | p-value | |
|---|---|---|---|---|
| Age | 16 | 61.9 ± 4.4 | 62.0 ± 5.0 | 0.917 |
| Male (%) | 16 | 71.7 ± 9.8 | 69.3 ± 8.2 | 0.471 |
| Hypertension | 12 | 53.1 ± 19.7 | 50.4 ± 18.8 | 0.733 |
| Diabetes mellitus | 9 | 20.1 ± 12.1 | 15.2 ± 8.6 | 0.333 |
| Stroke/TIA | 8 | 9.0 ± 3.7 | 8.9 ± 2.5 | 0.932 |
| CHA2DS2-VASC | 9 | 2.0 ± 0.4 | 2.1 ± 0.3 | 0.818 |
| LA diameter | 9 | 41.3 ± 2.7 | 41.0 ± 3.3 | 0.837 |
| AF duration (year) | 5 | 3.9 ± 2.0 | 4.3 ± 2.2 | 0.793 |
| Heart failure | 5 | 15.1 ± 19.1 | 14.8 ± 18.3 | 0.983 |
| LVEF (%) | 10 | 58.6 ± 4.2 | 58.6 ± 4.3 | 0.996 |
| CAD | 4 | 19.3 ± 6.7 | 16.9 ± 6.6 | 0.637 |
| BMI | 8 | 26.7 ± 2.4 | 26.8 ± 2.5 | 0.944 |
HP, high-power ablation; CP, conventional-power ablation; TIA, transient ischemic attack; LA, left atrium; AF, atrial fibrillation; LVEF, left ventricular ejection fraction; CAD, coronary artery disease; BMI, body mass index.